Structure

Physi-Chem Properties

Molecular Weight:  644.23
Volume:  648.212
LogP:  4.923
LogD:  3.136
LogS:  -3.758
# Rotatable Bonds:  11
TPSA:  165.12
# H-Bond Aceptor:  11
# H-Bond Donor:  4
# Rings:  5
# Heavy Atoms:  11

MedChem Properties

QED Drug-Likeness Score:  0.111
Synthetic Accessibility Score:  4.285
Fsp3:  0.278
Lipinski Rule-of-5:  Rejected
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Rejected
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -5.788
MDCK Permeability:  2.3628801500308327e-05
Pgp-inhibitor:  0.386
Pgp-substrate:  0.878
Human Intestinal Absorption (HIA):  0.321
20% Bioavailability (F20%):  0.144
30% Bioavailability (F30%):  0.984

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.025
Plasma Protein Binding (PPB):  96.9109878540039%
Volume Distribution (VD):  0.58
Pgp-substrate:  7.430647373199463%

ADMET: Metabolism

CYP1A2-inhibitor:  0.231
CYP1A2-substrate:  0.074
CYP2C19-inhibitor:  0.705
CYP2C19-substrate:  0.063
CYP2C9-inhibitor:  0.632
CYP2C9-substrate:  0.866
CYP2D6-inhibitor:  0.906
CYP2D6-substrate:  0.868
CYP3A4-inhibitor:  0.566
CYP3A4-substrate:  0.194

ADMET: Excretion

Clearance (CL):  7.08
Half-life (T1/2):  0.352

ADMET: Toxicity

hERG Blockers:  0.713
Human Hepatotoxicity (H-HT):  0.841
Drug-inuced Liver Injury (DILI):  0.57
AMES Toxicity:  0.21
Rat Oral Acute Toxicity:  0.049
Maximum Recommended Daily Dose:  0.368
Skin Sensitization:  0.907
Carcinogencity:  0.099
Eye Corrosion:  0.003
Eye Irritation:  0.016
Respiratory Toxicity:  0.047

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC76047

Natural Product ID:  NPC76047
Common Name*:   3'-Prenyl-4'-Methoxy-Isoflavone-7-O-Beta-D-(2''-O-P-Coumaroyl)Glucopyranoside
IUPAC Name:   [(2S,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-2-[3-[4-methoxy-3-(3-methylbut-2-enyl)phenyl]-4-oxochromen-7-yl]oxyoxan-3-yl] (E)-3-(4-hydroxyphenyl)prop-2-enoate
Synonyms:  
Standard InCHIKey:  ZJTGUFCATXASHE-XLTJWZCXSA-N
Standard InCHI:  InChI=1S/C36H36O11/c1-20(2)4-8-23-16-22(9-14-28(23)43-3)27-19-44-29-17-25(12-13-26(29)32(27)40)45-36-35(34(42)33(41)30(18-37)46-36)47-31(39)15-7-21-5-10-24(38)11-6-21/h4-7,9-17,19,30,33-38,41-42H,8,18H2,1-3H3/b15-7+/t30-,33-,34+,35-,36-/m1/s1
SMILES:  CC(=CCc1cc(ccc1OC)c1coc2cc(ccc2c1=O)O[C@H]1[C@@H]([C@H]([C@@H]([C@@H](CO)O1)O)O)OC(=O)/C=C/c1ccc(cc1)O)C
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL453212
PubChem CID:   6439258
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000261] Phenylpropanoids and polyketides
      • [CHEMONTID:0002506] Isoflavonoids
        • [CHEMONTID:0000507] Isoflavonoid O-glycosides

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO1231 Sopubia delphinifolia Species Orobanchaceae Eukaryota n.a. n.a. n.a. PMID[2348204]
NPO1231 Sopubia delphinifolia Species Orobanchaceae Eukaryota n.a. n.a. n.a. Database[TCMID]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT29 Organism Rattus norvegicus Rattus norvegicus Activity = 100.0 % PMID[488256]
NPT29 Organism Rattus norvegicus Rattus norvegicus Activity = 18.0 % PMID[488256]
NPT29 Organism Rattus norvegicus Rattus norvegicus Activity = 27.79 % PMID[488256]
NPT29 Organism Rattus norvegicus Rattus norvegicus Activity = 33.21 % PMID[488256]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC76047 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9565 High Similarity NPC473278
0.9565 High Similarity NPC260504
0.9565 High Similarity NPC89809
0.9563 High Similarity NPC124155
0.9563 High Similarity NPC257566
0.956 High Similarity NPC477628
0.956 High Similarity NPC477629
0.956 High Similarity NPC195685
0.956 High Similarity NPC270675
0.956 High Similarity NPC472994
0.956 High Similarity NPC210961
0.9509 High Similarity NPC188815
0.9503 High Similarity NPC139060
0.95 High Similarity NPC44947
0.95 High Similarity NPC472876
0.9451 High Similarity NPC217822
0.9451 High Similarity NPC11847
0.9451 High Similarity NPC101399
0.9451 High Similarity NPC221288
0.9451 High Similarity NPC474522
0.9448 High Similarity NPC5319
0.9441 High Similarity NPC80068
0.9437 High Similarity NPC47923
0.9437 High Similarity NPC303913
0.9437 High Similarity NPC101636
0.9434 High Similarity NPC43761
0.9434 High Similarity NPC73511
0.939 High Similarity NPC280642
0.939 High Similarity NPC218161
0.939 High Similarity NPC164704
0.939 High Similarity NPC469344
0.939 High Similarity NPC470712
0.939 High Similarity NPC96605
0.9383 High Similarity NPC205824
0.9383 High Similarity NPC85751
0.9383 High Similarity NPC129264
0.9383 High Similarity NPC19240
0.9379 High Similarity NPC190450
0.9379 High Similarity NPC131745
0.9379 High Similarity NPC298171
0.9375 High Similarity NPC472320
0.9371 High Similarity NPC23817
0.9371 High Similarity NPC43638
0.9371 High Similarity NPC161749
0.9371 High Similarity NPC197896
0.9371 High Similarity NPC313163
0.9371 High Similarity NPC156457
0.9371 High Similarity NPC258035
0.9349 High Similarity NPC75574
0.9333 High Similarity NPC470716
0.9333 High Similarity NPC470714
0.9333 High Similarity NPC470715
0.9325 High Similarity NPC68592
0.9325 High Similarity NPC298666
0.9325 High Similarity NPC262222
0.9321 High Similarity NPC278419
0.9321 High Similarity NPC183672
0.9321 High Similarity NPC66087
0.9321 High Similarity NPC179198
0.9317 High Similarity NPC97812
0.9313 High Similarity NPC22062
0.9313 High Similarity NPC473634
0.9313 High Similarity NPC138811
0.9308 High Similarity NPC45165
0.9308 High Similarity NPC471787
0.9308 High Similarity NPC127406
0.9286 High Similarity NPC471030
0.9281 High Similarity NPC231787
0.9277 High Similarity NPC472993
0.9277 High Similarity NPC168789
0.9273 High Similarity NPC92815
0.9259 High Similarity NPC259834
0.9259 High Similarity NPC475382
0.9255 High Similarity NPC271270
0.9255 High Similarity NPC473623
0.9255 High Similarity NPC97285
0.9255 High Similarity NPC142860
0.9255 High Similarity NPC246469
0.925 High Similarity NPC129827
0.925 High Similarity NPC65003
0.925 High Similarity NPC473512
0.925 High Similarity NPC44931
0.9245 High Similarity NPC470605
0.9245 High Similarity NPC99233
0.9245 High Similarity NPC27408
0.9245 High Similarity NPC95090
0.9245 High Similarity NPC470604
0.9245 High Similarity NPC470603
0.9231 High Similarity NPC477860
0.9231 High Similarity NPC475161
0.9226 High Similarity NPC477895
0.9217 High Similarity NPC137871
0.9217 High Similarity NPC257011
0.9217 High Similarity NPC288152
0.9217 High Similarity NPC47140
0.9217 High Similarity NPC9002
0.9217 High Similarity NPC67134
0.9207 High Similarity NPC64425
0.9202 High Similarity NPC473644
0.9202 High Similarity NPC311850
0.9198 High Similarity NPC216496
0.9198 High Similarity NPC175513
0.9198 High Similarity NPC48093
0.9198 High Similarity NPC85707
0.9198 High Similarity NPC470125
0.9198 High Similarity NPC224530
0.9198 High Similarity NPC129217
0.9198 High Similarity NPC159579
0.9198 High Similarity NPC259957
0.9187 High Similarity NPC206378
0.9187 High Similarity NPC170475
0.9187 High Similarity NPC473657
0.9187 High Similarity NPC295613
0.9182 High Similarity NPC106625
0.9182 High Similarity NPC83283
0.9182 High Similarity NPC29763
0.9182 High Similarity NPC78021
0.9182 High Similarity NPC143851
0.9182 High Similarity NPC268950
0.9182 High Similarity NPC211158
0.9182 High Similarity NPC108706
0.9182 High Similarity NPC87304
0.9182 High Similarity NPC39360
0.9182 High Similarity NPC210003
0.9176 High Similarity NPC199172
0.9176 High Similarity NPC293227
0.9176 High Similarity NPC35924
0.9176 High Similarity NPC473717
0.9176 High Similarity NPC475662
0.9176 High Similarity NPC473631
0.9176 High Similarity NPC162394
0.9176 High Similarity NPC156785
0.9176 High Similarity NPC241781
0.9172 High Similarity NPC179862
0.9162 High Similarity NPC172033
0.9162 High Similarity NPC88560
0.9162 High Similarity NPC25724
0.9162 High Similarity NPC208668
0.9162 High Similarity NPC175230
0.9157 High Similarity NPC175429
0.9157 High Similarity NPC209550
0.9157 High Similarity NPC298778
0.9157 High Similarity NPC199079
0.9157 High Similarity NPC78734
0.9157 High Similarity NPC277532
0.9157 High Similarity NPC210808
0.9157 High Similarity NPC138990
0.9157 High Similarity NPC150767
0.9146 High Similarity NPC294722
0.9146 High Similarity NPC135358
0.9146 High Similarity NPC287889
0.9141 High Similarity NPC27942
0.9141 High Similarity NPC240306
0.9136 High Similarity NPC271479
0.9136 High Similarity NPC187379
0.913 High Similarity NPC60966
0.913 High Similarity NPC108831
0.913 High Similarity NPC470606
0.913 High Similarity NPC182634
0.9125 High Similarity NPC26195
0.9125 High Similarity NPC97052
0.9125 High Similarity NPC169248
0.9125 High Similarity NPC72649
0.9125 High Similarity NPC39351
0.9123 High Similarity NPC21359
0.9123 High Similarity NPC249560
0.9123 High Similarity NPC106700
0.9123 High Similarity NPC223860
0.9123 High Similarity NPC25946
0.9123 High Similarity NPC470720
0.9123 High Similarity NPC275977
0.9123 High Similarity NPC470717
0.9123 High Similarity NPC470713
0.9123 High Similarity NPC460984
0.9119 High Similarity NPC88484
0.9119 High Similarity NPC259767
0.9119 High Similarity NPC10807
0.9119 High Similarity NPC150123
0.9119 High Similarity NPC56232
0.9119 High Similarity NPC259182
0.9119 High Similarity NPC121001
0.9119 High Similarity NPC244583
0.9119 High Similarity NPC161881
0.9118 High Similarity NPC469371
0.9112 High Similarity NPC139571
0.9112 High Similarity NPC267549
0.9112 High Similarity NPC217520
0.9112 High Similarity NPC35167
0.9112 High Similarity NPC472387
0.9107 High Similarity NPC214621
0.9107 High Similarity NPC34267
0.9107 High Similarity NPC68381
0.9107 High Similarity NPC223426
0.9107 High Similarity NPC63105
0.9107 High Similarity NPC81042
0.9102 High Similarity NPC256760
0.9091 High Similarity NPC477613
0.9091 High Similarity NPC70441
0.9091 High Similarity NPC12013
0.9091 High Similarity NPC11432

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC76047 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.9448 High Similarity NPD7804 Clinical (unspecified phase)
0.9371 High Similarity NPD4381 Clinical (unspecified phase)
0.9012 High Similarity NPD7075 Discontinued
0.8994 High Similarity NPD4380 Phase 2
0.8982 High Similarity NPD7054 Approved
0.8929 High Similarity NPD7074 Phase 3
0.8929 High Similarity NPD7472 Approved
0.8882 High Similarity NPD7808 Phase 3
0.8827 High Similarity NPD7096 Clinical (unspecified phase)
0.8824 High Similarity NPD6559 Discontinued
0.8824 High Similarity NPD7251 Discontinued
0.882 High Similarity NPD7411 Suspended
0.8773 High Similarity NPD8443 Clinical (unspecified phase)
0.8765 High Similarity NPD6801 Discontinued
0.8765 High Similarity NPD6797 Phase 2
0.8698 High Similarity NPD3818 Discontinued
0.869 High Similarity NPD7852 Clinical (unspecified phase)
0.8663 High Similarity NPD4338 Clinical (unspecified phase)
0.8613 High Similarity NPD8313 Approved
0.8613 High Similarity NPD8312 Approved
0.8598 High Similarity NPD7819 Suspended
0.8588 High Similarity NPD7879 Clinical (unspecified phase)
0.858 High Similarity NPD6168 Clinical (unspecified phase)
0.858 High Similarity NPD6166 Phase 2
0.858 High Similarity NPD6167 Clinical (unspecified phase)
0.8562 High Similarity NPD7410 Clinical (unspecified phase)
0.8494 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.8494 Intermediate Similarity NPD7768 Phase 2
0.8485 Intermediate Similarity NPD2393 Clinical (unspecified phase)
0.8485 Intermediate Similarity NPD8455 Phase 2
0.8447 Intermediate Similarity NPD4378 Clinical (unspecified phase)
0.8344 Intermediate Similarity NPD5403 Approved
0.8333 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.8313 Intermediate Similarity NPD1934 Approved
0.8302 Intermediate Similarity NPD1549 Phase 2
0.8294 Intermediate Similarity NPD6959 Discontinued
0.8272 Intermediate Similarity NPD6799 Approved
0.8239 Intermediate Similarity NPD1550 Clinical (unspecified phase)
0.8239 Intermediate Similarity NPD1552 Clinical (unspecified phase)
0.8221 Intermediate Similarity NPD5401 Approved
0.8218 Intermediate Similarity NPD5844 Phase 1
0.8214 Intermediate Similarity NPD5402 Approved
0.8214 Intermediate Similarity NPD3817 Phase 2
0.8201 Intermediate Similarity NPD8151 Discontinued
0.8197 Intermediate Similarity NPD8090 Clinical (unspecified phase)
0.8176 Intermediate Similarity NPD2796 Approved
0.8137 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.8113 Intermediate Similarity NPD1510 Phase 2
0.8103 Intermediate Similarity NPD7473 Discontinued
0.8095 Intermediate Similarity NPD7584 Approved
0.8084 Intermediate Similarity NPD6599 Discontinued
0.8066 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.8047 Intermediate Similarity NPD2801 Approved
0.8035 Intermediate Similarity NPD6232 Discontinued
0.8032 Intermediate Similarity NPD7435 Discontinued
0.8024 Intermediate Similarity NPD7458 Discontinued
0.8021 Intermediate Similarity NPD7782 Clinical (unspecified phase)
0.8021 Intermediate Similarity NPD7783 Phase 2
0.8012 Intermediate Similarity NPD3749 Approved
0.7975 Intermediate Similarity NPD1878 Clinical (unspecified phase)
0.7975 Intermediate Similarity NPD3750 Approved
0.7939 Intermediate Similarity NPD1511 Approved
0.7919 Intermediate Similarity NPD5494 Approved
0.7904 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.7895 Intermediate Similarity NPD7871 Phase 2
0.7895 Intermediate Similarity NPD7870 Phase 2
0.7876 Intermediate Similarity NPD7875 Clinical (unspecified phase)
0.7876 Intermediate Similarity NPD7874 Approved
0.7872 Intermediate Similarity NPD6778 Approved
0.7872 Intermediate Similarity NPD6779 Approved
0.7872 Intermediate Similarity NPD6777 Approved
0.7872 Intermediate Similarity NPD6781 Approved
0.7872 Intermediate Similarity NPD6782 Approved
0.7872 Intermediate Similarity NPD6780 Approved
0.7872 Intermediate Similarity NPD6776 Approved
0.7866 Intermediate Similarity NPD4628 Phase 3
0.7865 Intermediate Similarity NPD7585 Approved
0.7862 Intermediate Similarity NPD1240 Approved
0.7853 Intermediate Similarity NPD7228 Approved
0.7849 Intermediate Similarity NPD3882 Suspended
0.7844 Intermediate Similarity NPD1512 Approved
0.7842 Intermediate Similarity NPD7697 Approved
0.7842 Intermediate Similarity NPD7698 Approved
0.7842 Intermediate Similarity NPD7696 Phase 3
0.7812 Intermediate Similarity NPD7583 Approved
0.7798 Intermediate Similarity NPD920 Approved
0.7778 Intermediate Similarity NPD7685 Pre-registration
0.7772 Intermediate Similarity NPD7701 Phase 2
0.7771 Intermediate Similarity NPD7199 Phase 2
0.7764 Intermediate Similarity NPD1607 Approved
0.7753 Intermediate Similarity NPD3751 Discontinued
0.7751 Intermediate Similarity NPD1653 Approved
0.7736 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.773 Intermediate Similarity NPD2935 Discontinued
0.773 Intermediate Similarity NPD1551 Phase 2
0.7722 Intermediate Similarity NPD5953 Discontinued
0.7709 Intermediate Similarity NPD7286 Phase 2
0.7708 Intermediate Similarity NPD8319 Approved
0.7708 Intermediate Similarity NPD8320 Phase 1
0.7705 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.7697 Intermediate Similarity NPD1243 Approved
0.7696 Intermediate Similarity NPD6823 Phase 2
0.7679 Intermediate Similarity NPD642 Clinical (unspecified phase)
0.7672 Intermediate Similarity NPD7699 Phase 2
0.7672 Intermediate Similarity NPD7700 Phase 2
0.7669 Intermediate Similarity NPD3748 Approved
0.7665 Intermediate Similarity NPD643 Clinical (unspecified phase)
0.7663 Intermediate Similarity NPD8150 Discontinued
0.7653 Intermediate Similarity NPD7801 Approved
0.7636 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.763 Intermediate Similarity NPD1465 Phase 2
0.7627 Intermediate Similarity NPD3787 Discontinued
0.7625 Intermediate Similarity NPD2313 Discontinued
0.7606 Intermediate Similarity NPD6534 Approved
0.7606 Intermediate Similarity NPD6535 Approved
0.7602 Intermediate Similarity NPD3226 Approved
0.7584 Intermediate Similarity NPD7184 Clinical (unspecified phase)
0.7574 Intermediate Similarity NPD2533 Approved
0.7574 Intermediate Similarity NPD2534 Approved
0.7574 Intermediate Similarity NPD8155 Clinical (unspecified phase)
0.7574 Intermediate Similarity NPD2532 Approved
0.7572 Intermediate Similarity NPD37 Approved
0.7561 Intermediate Similarity NPD2799 Discontinued
0.7557 Intermediate Similarity NPD919 Approved
0.7557 Intermediate Similarity NPD6234 Discontinued
0.7543 Intermediate Similarity NPD4965 Approved
0.7543 Intermediate Similarity NPD4966 Approved
0.7543 Intermediate Similarity NPD4967 Phase 2
0.7516 Intermediate Similarity NPD4907 Clinical (unspecified phase)
0.7515 Intermediate Similarity NPD6143 Clinical (unspecified phase)
0.75 Intermediate Similarity NPD5808 Clinical (unspecified phase)
0.75 Intermediate Similarity NPD6832 Phase 2
0.7486 Intermediate Similarity NPD7240 Approved
0.7485 Intermediate Similarity NPD5124 Phase 1
0.7485 Intermediate Similarity NPD2800 Approved
0.7485 Intermediate Similarity NPD5123 Clinical (unspecified phase)
0.7485 Intermediate Similarity NPD1933 Approved
0.7473 Intermediate Similarity NPD8434 Phase 2
0.7471 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.747 Intermediate Similarity NPD7266 Discontinued
0.7455 Intermediate Similarity NPD7033 Discontinued
0.7446 Intermediate Similarity NPD4419 Clinical (unspecified phase)
0.7444 Intermediate Similarity NPD7784 Clinical (unspecified phase)
0.7439 Intermediate Similarity NPD6651 Approved
0.7421 Intermediate Similarity NPD4363 Phase 3
0.7421 Intermediate Similarity NPD4360 Phase 2
0.7414 Intermediate Similarity NPD7615 Clinical (unspecified phase)
0.7412 Intermediate Similarity NPD7390 Discontinued
0.7407 Intermediate Similarity NPD6798 Discontinued
0.7394 Intermediate Similarity NPD7097 Phase 1
0.7391 Intermediate Similarity NPD4908 Phase 1
0.7368 Intermediate Similarity NPD6214 Clinical (unspecified phase)
0.7368 Intermediate Similarity NPD6212 Phase 3
0.7368 Intermediate Similarity NPD6213 Phase 3
0.7365 Intermediate Similarity NPD2346 Discontinued
0.7337 Intermediate Similarity NPD6398 Clinical (unspecified phase)
0.7312 Intermediate Similarity NPD1203 Approved
0.7278 Intermediate Similarity NPD1652 Phase 2
0.7278 Intermediate Similarity NPD1247 Approved
0.7277 Intermediate Similarity NPD7930 Approved
0.7267 Intermediate Similarity NPD2798 Approved
0.7262 Intermediate Similarity NPD2344 Approved
0.7256 Intermediate Similarity NPD6233 Phase 2
0.7238 Intermediate Similarity NPD7229 Phase 3
0.7235 Intermediate Similarity NPD7003 Approved
0.7212 Intermediate Similarity NPD1613 Approved
0.7212 Intermediate Similarity NPD1612 Clinical (unspecified phase)
0.7208 Intermediate Similarity NPD7680 Approved
0.7198 Intermediate Similarity NPD3926 Phase 2
0.7195 Intermediate Similarity NPD3268 Approved
0.7193 Intermediate Similarity NPD6190 Approved
0.7179 Intermediate Similarity NPD8285 Discontinued
0.7174 Intermediate Similarity NPD7893 Clinical (unspecified phase)
0.717 Intermediate Similarity NPD1091 Approved
0.717 Intermediate Similarity NPD1547 Clinical (unspecified phase)
0.7169 Intermediate Similarity NPD230 Phase 1
0.7169 Intermediate Similarity NPD6355 Discontinued
0.7143 Intermediate Similarity NPD8058 Clinical (unspecified phase)
0.7143 Intermediate Similarity NPD5711 Approved
0.7143 Intermediate Similarity NPD4308 Phase 3
0.7143 Intermediate Similarity NPD1509 Clinical (unspecified phase)
0.7143 Intermediate Similarity NPD7501 Clinical (unspecified phase)
0.7143 Intermediate Similarity NPD8059 Phase 3
0.7143 Intermediate Similarity NPD5710 Approved
0.7125 Intermediate Similarity NPD9717 Approved
0.712 Intermediate Similarity NPD4287 Approved
0.7119 Intermediate Similarity NPD5889 Approved
0.7119 Intermediate Similarity NPD5890 Approved
0.7108 Intermediate Similarity NPD943 Approved
0.7101 Intermediate Similarity NPD6100 Approved
0.7101 Intermediate Similarity NPD5408 Approved
0.7101 Intermediate Similarity NPD5405 Approved
0.7101 Intermediate Similarity NPD5404 Approved
0.7101 Intermediate Similarity NPD6099 Approved
0.7101 Intermediate Similarity NPD5406 Approved
0.7099 Intermediate Similarity NPD2797 Approved
0.7095 Intermediate Similarity NPD4288 Approved
0.7093 Intermediate Similarity NPD2309 Approved
0.7092 Intermediate Similarity NPD7237 Clinical (unspecified phase)
0.7088 Intermediate Similarity NPD8127 Discontinued

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data